Polyrizon net loss widens 705% to USD 1.42 million for six months ended June 30, 2026
Bitget2026/09/28 20:16- Polyrizon posted a net loss of USD 1.42 million for the six months ended June 30, 2026, and a basic and diluted loss per share of USD 0.79.
- Operating loss widened to USD 4.32 million, while research and development expenses rose to USD 1.38 million.
- Financial income, net increased to USD 2.9 million, including USD 2.59 million from fair value revaluation of investments in shares and warrants.
- Cash and cash equivalents climbed to USD 8.41 million at June 30, 2026, while net cash used in operating activities totaled USD 1.96 million.
- Total assets rose to USD 24.86 million, and shareholders’ equity increased to USD 24.41 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Vaxcyte shares soar following successful late-stage clinical trial for pneumococcal vaccine
October 5 – Vaxcyte (PCVX.O) shares surged 26% pre-market to $71.17. Vaxcyte announced that its 31-valent pneumococcal vaccine VAX-31 met all primary endpoints in a late-stage clinical trial, and generated immune responses comparable to or stronger than Pfizer’s Prevnar 20 and Merck’s Capvaxive. The safety and tolerability of the vaccine were similar to existing vaccines. Vaxcyte expects results from two additional late-stage clinical trials in the first half of 2027, and plans to submit a marketing application to the FDA in the first half of 2028. As of the previous trading session’s close, the stock had risen 22.4% year-to-date.
Linde to release Q3 2026 results, hosts investor conference call and webcast
Linde will publish third-quarter 2026 results on Oct. 29, 2026 by 6:00 a.m. EDT (11:00 a.m. CET). Conference call webcast set for Oct. 29, 2026 at 9:00 a.m. EDT (2:00 p.m. CET). Web replay available from Oct. 29, 2026 at 10:30 a.m. EDT (3:30 p.m. CET) via https://www.linde.com/investors/financial-reports. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Linde plc published the original content used to generate this news brief via EQS News (Ref. ID: corporate_2409690_en) on October 05, 2026, and is solely responsible for the information contained therein.
Bitcoin (BTC) Rejected at $87K Again, Cardano (ADA) Soars 11%: Market Watch
BUZZ - PTC shares soar after Schneider Electric agrees to acquire PTC for $22.6 billion
On October 5th, shares of software company PTC (PTC.O) surged by 34.6% in pre-market trading to $193.8 after France's Schneider Electric (SCHN.PA) agreed to acquire PTC in an all-cash deal valuing PTC's equity at approximately $22.6 billion. The offer price of $205 per share represents an enterprise value of $23.7 billion, a 42.3% premium over PTC’s previous closing price. According to data from London Stock Exchange Group (LSEG), this is the largest acquisition in Schneider Electric’s history. Following the agreement to acquire private AI software and industrial data provider Cognite Holding in June this year, this deal marks another significant step in SCHN’s expansion into the software sector. As of the previous day’s close, PTC shares were down 17.3% year-to-date, while SCHN’s shares had risen 17.4% for the year.